Insights

More Articles Back to Article

CDC committee recommends warning on J&J vaccine

New recommendations from the CDC's Advisory Committee on Immunization Practices for using the Janssen/Johnson & Johnson COVID-19 vaccine included a warning on the risk of thrombosis with thrombocytopenia syndrome among women ages 18 to 49. The recommendations, published in the CDC's Morbidity and Mortality Weekly Report, were based on a risk-benefit analysis that found the benefits of the vaccine outweighed the risks, and the FDA has added a warning to the vaccine's emergency use authorization. AAFP News (4/29)

Read full article now.

Articles are only one benefit of being a DIA member. Learn more and join today so you don’t miss another article!